GL1X · GenesisL1 explorer

Research workbench

Discovery of novel, dual mechanism ERK inhibitors by affinity selection screening of an inactive kinase state

Analyse Discovery of novel, dual mechanism ERK inhibitors by affinity selection… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4QYY
Type
protein
Length
337 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase 1
EC
2.7.11.24
UniProt
P63086
Ligands
3G7, SO4
Pockets
4 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase 1 (EC 2.7.11.24)protein33741% helix, 15% strandP63086

Ligands and binding sites

  • 3G7 · (3R)-1-{2-[4-(4-acetylphenyl)piperazin-1-yl]-2-oxoethyl}-N-(3-chloro-4-hydroxyphenyl)pyrrolidine-3-carboxamide · ligand · chains A
  • SO4 · Sulfate ion · ion · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14710.700.80433G7
21220.520.8131empty
31370.490.7920SO4
4970.390.7614empty

Compared structures

  • 4QYY · Discovery of Novel, Dual Mechanism ERK Inhibitors by Affinity Selection Screening of an… · the same entry in another collection · chain A against A, TM-score 1.00
  • P63086 · AlphaFold monomer V2.0 prediction for mitogen-activated protein kinase 1 (P63086) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.